S.13.1 Safety and efficacy of rituximab in SSc: an analysis from the European Scleroderma Trial and Research Group

MLA

Jordan, S., et al. S.13.1 Safety and Efficacy of Rituximab in SSc: An Analysis from the European Scleroderma Trial and Research Group. Aug. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......805..a15654ed6b1b70c4c5d4a8b1610b7a78&authtype=sso&custid=ns315887.

APA

Jordan, S., Distler, J., Maurer, B., Allanore, Y., Van Laar, J., Distler, O., Fraticelli, P., Pomponio, G., Gabrielli, B., Riboldi, P., Ferraccioli, G., Valentini, G., Bombardieri, S., Malorni, W., Gerli, R., Lunardi, C., Faggioli, P., Corvetta, A., Gabrielli, A., … Bazzichi, L. (2017). S.13.1 Safety and efficacy of rituximab in SSc: an analysis from the European Scleroderma Trial and Research Group.

Chicago

Jordan, S., J. Distler, B. Maurer, Y. Allanore, J. Van Laar, O. Distler, P. Fraticelli, et al. 2017. “S.13.1 Safety and Efficacy of Rituximab in SSc: An Analysis from the European Scleroderma Trial and Research Group,” August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......805..a15654ed6b1b70c4c5d4a8b1610b7a78&authtype=sso&custid=ns315887.